Therapy resistance/chronicity, their determinants and potential solutions
Open Access
- 1 February 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Archiv Fur Psychiatrie Und Nervenkrankheiten
- Vol. 270 (1), 1-2
- https://doi.org/10.1007/s00406-020-01101-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Benzodiazepines in anxiety disorders: Reassessment of usefulness and safetyThe World Journal of Biological Psychiatry, 2018
- The relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practiceArchiv Fur Psychiatrie Und Nervenkrankheiten, 2016
- Pharmacological treatment of negative symptoms in schizophreniaArchiv Fur Psychiatrie Und Nervenkrankheiten, 2015
- What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialArchiv Fur Psychiatrie Und Nervenkrankheiten, 2014
- Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factorsArchiv Fur Psychiatrie Und Nervenkrankheiten, 2014
- Outcomes of 1014 naturalistically treated inpatients with major depressive episodeEuropean Neuropsychopharmacology, 2010
- Risperidone plasma levels, clinical response and side–effectsArchiv Fur Psychiatrie Und Nervenkrankheiten, 2004